Abstract
This study explores using the restricted mean time lost to quantify treatment effects from cardiovascular therapy.
Publication types
-
Comparative Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use*
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / mortality
-
Data Interpretation, Statistical*
-
Humans
-
Mortality
-
Propanolamines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Statistics as Topic
-
Time Factors
-
Treatment Outcome
Substances
-
Adrenergic beta-Antagonists
-
Propanolamines
-
bucindolol